We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GERN market cap is 2.79B. The company's latest EPS is USD -0.3104 and P/E is -14.82.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21k | 29k | 164k | 23k | 304k |
| Operating Income | -40.09M | -51.95M | -47.61M | -54.29M | -56.13M |
| Net Income | -38.12M | -49.23M | -44.81M | -51.97M | -55.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 460k | 253k | 1.39M | 596k | 237k |
| Operating Income | -72.7M | -76.91M | -114M | -138.55M | -193.94M |
| Net Income | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 424.88M | 415.3M | 413.02M | 394.08M | 482.07M |
| Total Liabilities | 98.82M | 116.87M | 122.4M | 146.13M | 137.21M |
| Total Equity | 326.06M | 298.43M | 290.61M | 247.95M | 344.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 165.52M | 270.73M | 226.03M | 190.58M | 394.08M |
| Total Liabilities | 30.36M | 59.78M | 99.62M | 110.58M | 146.13M |
| Total Equity | 135.16M | 210.95M | 126.42M | 80M | 247.95M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -46.37M | -75.97M | -126.81M | -167.74M | -62.25M |
| Investing | -178.73M | -223.18M | -227.89M | -180.32M | 34.21M |
| Financing | 281.05M | 299.39M | 328.74M | 362.02M | 147.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.9M | -66.65M | -95.56M | -127.38M | -167.74M |
| Investing | 27.4M | -105.32M | 71.95M | 62.07M | -180.32M |
| Financing | 19.57M | 168.35M | 48.56M | 87.26M | 362.02M |
| Market Cap | 2.79B |
| Price to Earnings Ratio | -14.82 |
| Price to Sales Ratio | 11.5k |
| Price to Cash Ratio | 38.95 |
| Price to Book Ratio | 11 |
| Dividend Yield | - |
| Shares Outstanding | 593.13M |
| Average Volume (1 week) | 8.15M |
| Average Volume (1 Month) | 8.11M |
| 52 Week Change | 53.42% |
| 52 Week High | 5.34 |
| 52 Week Low | 1.64 |
| Spread (Intraday) | 0.05 (1.07%) |
| Company Name | Geron Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.geron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
